Xbrane Biopharma AB
XBRANE SE0007789409
ICB 2010 : Health Care / Health CareAnnual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 38% | -26% | -88% | -98% | -12% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Karl Martin Erik Ämark CEO |
0.17 SEK |
1,864,223 Bought |
318,782 SEK |
20/01/2025 | 17/01/2025 |
| Karl Martin Erik Ämark CEO |
0.17 SEK |
1,864,223 Sold |
315,054 SEK |
20/01/2025 | 17/01/2025 |
| Karl Martin Erik Ämark CEO |
0.17 SEK |
1,500,000 Sold |
256,500 SEK |
20/01/2025 | 16/01/2025 |
| Siavash Bashiri VP |
0.17 SEK |
1,500,000 Bought |
256,500 SEK |
19/01/2025 | 16/01/2025 |
| Karl Martin Erik Ämark CEO |
0.17 SEK |
1,500,000 Bought |
256,500 SEK |
20/01/2025 | 16/01/2025 |
| Siavash Bashiri VP |
0.17 SEK |
1,519,932 Sold |
260,212 SEK |
19/01/2025 | 16/01/2025 |
| Karin Johansson Wingstrand DIR |
29.90 SEK |
5,000 Bought |
149,500 SEK |
19/09/2023 | 19/09/2023 |
| Karl Martin Erik Ämark CEO |
32.05 SEK |
4,000 Sold |
128,200 SEK |
12/09/2023 | 12/09/2023 |
| Karl Martin Erik Ämark CEO |
32.25 SEK |
4,000 Bought |
129,000 SEK |
12/09/2023 | 12/09/2023 |
| Karl Martin Erik Ämark CEO |
31.07 SEK |
2,000 Sold |
62,140 SEK |
12/09/2023 | 11/09/2023 |